Increased soluble Mer receptor levels in lupus relate to disease activity
Author Information
Author(s): Wu Jun, Ekman Carl, Jönsen Andreas, Sturfelt Gunnar, Bengtsson Anders A, Gottsäter Anders, Lindblad Bengt, Lindqvist Elisabet, Saxne Tore, Dahlbäck Björn
Primary Institution: Lund University
Hypothesis
The study aimed to determine if plasma levels of soluble Mer and Tyro3 are increased in systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), or critical limb ischemia (CLI).
Conclusion
The study found that plasma concentrations of soluble Mer and Tyro3 were significantly increased in patients with active SLE and RA, indicating that receptor shedding is influenced by these autoimmune diseases.
Supporting Evidence
- Increased sMer levels were found in SLE patients, correlating with higher disease activity scores.
- SLE patients with nephritis had the highest sMer levels.
- After therapy, sMer levels decreased alongside disease activity scores.
Takeaway
This study shows that people with lupus have higher levels of a specific protein in their blood, which can help doctors understand how active the disease is.
Methodology
Plasma concentrations were tested using ELISA kits in patients with SLE, RA, and CLI.
Limitations
The study may not account for all variables affecting sMer levels, and the sample size for some groups may limit generalizability.
Participant Demographics
Patients included 96 with SLE (11 men, 85 women) and 183 with RA (68 men, 115 women).
Statistical Information
P-Value
P < 0.0001 for SLE, P = 0.0236 for RA
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website